Hom, S., & Pisano, M. (2017). Reslizumab (Cinqair): An Interleukin-5 Antagonist for Severe Asthma of the Eosinophilic Phenotype. P T.
استشهاد بنمط شيكاغوHom, Selina, و Michele Pisano. "Reslizumab (Cinqair): An Interleukin-5 Antagonist for Severe Asthma of the Eosinophilic Phenotype." P T 2017.
MLA استشهادHom, Selina, و Michele Pisano. "Reslizumab (Cinqair): An Interleukin-5 Antagonist for Severe Asthma of the Eosinophilic Phenotype." P T 2017.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.